Sky Oral Rinse
Sky Oral Rinse is an FDA drug label for the active ingredient CHLORHEXIDINE GLUCONATE manufactured by McKesson administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220926.
- Generic name
- CHLORHEXIDINE GLUCONATE
- Manufacturer
- McKesson
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 63739-052
- Application
- ANDA077789
- Label effective
- 20220926
About this product
Sky Oral Rinse is an FDA-registered drug product whose active ingredient is CHLORHEXIDINE GLUCONATE. It is labelled by McKesson taken by oral and marketed as a human prescription drug product. Identifiers on file: NDC 63739-052, application ANDA077789, label effective 20220926. It is one of 38 FDA drug label records sharing the active ingredient CHLORHEXIDINE GLUCONATE. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.
What it is used for
Across FDA labelling, products containing CHLORHEXIDINE GLUCONATE are most often described in connection with: chlorhexidine gluconate, oral rinse, dental visits, part professional, treatment gingivitis, characterized redness, gingivae including, gingival bleeding. Wording differs between labels, and the full indications section on this page takes precedence when it is present.
Indications & Usage
INDICATION Chlorhexidine gluconate oral rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine gluconate oral rinse has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS.
Dosage & Administration
DOSAGE AND ADMINISTRATION Chlorhexidine gluconate oral rinse therapy should be initiated directly following a dental prophylaxis. Patients using chlorhexidine gluconate oral rinse should be reevaluated and given a thorough prophylaxis at intervals no longer than six months. Recommended use is twice daily rinsing for 30 seconds, morning and evening after tooth brushing. Usual dosage is 15 ml of undiluted chlorhexidine gluconate oral rinse. Patients should be instructed to not rinse with water, or other mouthwashes, brush teeth, or eat immediately after using chlorhexidine gluconate oral rinse. Chlorhexidine gluconate oral rinse is not intended for ingestion and should be expectorated after rinsing.
Contraindications
CONTRAINDICATIONS Chlorhexidine gluconate oral rinse should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.
Warnings
WARNINGS The effect of chlorhexidine gluconate oral rinse on periodontitis has not been determined. An increase in supragingival calculus was noted in clinical testing in chlorhexidine gluconate oral rinse users compared with control users. It is not known if chlorhexidine gluconate oral rinse use results in an increase in subgingival calulus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months. Anaphylaxis, as well as serious allergic reactions, have been reported during postmarketing use with dental products containing chlorhexidine. SEE CONTRAINDICATIONS.
Adverse Reactions
ADVERSE REACTIONS The most common side effects associated with chlohexidine gluconate oral rinses are: 1) an increase in staining of teeth and other oral surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception; see WARNINGS and PRECAUTIONS. Oral irritation and local allergy-type symptoms have been spontaneously reported as side effects associated with use of chlorhexidine gluconate oral rinse. The following oral mucosal side effects were reported during placebo-controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation, coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occured at a frequency of less than 1%. Among post marketing reports, the most frequently reported oral mucosal symptoms associated with chlorhexidine gluconate oral rinse are stomatitis, gingivitis, glossitis, ulcer, dry mouth, hypesthesia, glossal edema, and paresthesia. Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using chlorhexidine gluconate oral rinse. There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadenitis) reported in patients using chlorhexidine gluconate oral rinse.
More products with the same ingredient
CHLORHEXIDINE GLUCONATEANTISEPTIC SKIN CLEANSER
View labelANTISEPTIC SKIN CLEANSER
View labelBactoshield CHG
View labelBactoshield CHG
View labelBactoshield CHG Chlorhexidine Gluconate
View labelCHLORHEXIDINE GLUCONATE
View labelCHLORHEXIDINE GLUCONATE
View labelCHLORHEXIDINE GLUCONATE
View labelHow products containing CHLORHEXIDINE GLUCONATE compare
FDA lists 38 drug label records with CHLORHEXIDINE GLUCONATE as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.
| Dosage form | Products | Manufacturer | Products |
|---|---|---|---|
| — | — | Xttrium Laboratories, Inc. | 11 |
| — | — | AVA, Inc. | 9 |
| — | — | Colgate Oral Pharmaceuticals, Inc. | 2 |
| — | — | SC Johnson Professional USA, Inc. | 2 |
| — | — | XINXIANG XINDA TECHNOLOGY CO.,LTD | 2 |
Recall and safety notices
5 FDA recall record(s) match this product name or manufacturer. A match means the firm or product name appears in the enforcement report; confirm lot numbers and dates against the official FDA notice before acting.
| Recall | Product | Firm | Class | Status | Reported |
|---|---|---|---|---|---|
| D-0714-2026 | Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01 | McKesson | Class II | Ongoing | 20260708 |
| D-0353-2026 | UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, NDC 69448-025-63 | McKesson | Class I | Ongoing | 20260218 |
| D-0539-2025 | EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02. | Mckesson Medical-Surgical Inc. Corporate Office | Class II | Ongoing | 20250730 |
| D-0540-2025 | BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK. | Mckesson Medical-Surgical Inc. Corporate Office | Class II | Ongoing | 20250730 |
| D-0538-2025 | PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21 | Mckesson Medical-Surgical Inc. Corporate Office | Class II | Ongoing | 20250730 |
Frequently asked questions
What is Sky Oral Rinse used for?
INDICATION Chlorhexidine gluconate oral rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine gluconate oral rinse has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having …
Who makes Sky Oral Rinse?
McKesson is the labeler of record for Sky Oral Rinse. 38 FDA label records share the active ingredient CHLORHEXIDINE GLUCONATE, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.
What form does Sky Oral Rinse come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.
Is Sky Oral Rinse prescription or over-the-counter?
The FDA label for this product is recorded as human prescription drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.
Are there other products containing CHLORHEXIDINE GLUCONATE?
Yes. 38 FDA drug label records list CHLORHEXIDINE GLUCONATE as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.
Has Sky Oral Rinse been recalled?
5 FDA recall record(s) match this product name or manufacturer. Review the recall and safety notices section on this page and confirm lot numbers against the official FDA enforcement report.
Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.
This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.